Lansoprazole Capsule, Delayed Release
Product Images NDC 82009-039

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 82009-039). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazolefigure1 (Lansoprazolefigure1)

FDA Label Image

Lansoprazolefigure2 (Lansoprazolefigure2)

FDA Label Image

Lansoprazolestructure (Lansoprazolestructure)

FDA Label Image

Lansoprazole-30mg-500s-count-container-label (Lansoprazole 30mg 500s Count Container Label)

Lansoprazole-30mg-500s-count-container-label (Lansoprazole 30mg 500s Count Container Label)
This is a description of Lansoprazole Delayed-Release Capsules which come in 30mg capsules. The capsules are enteric-coated pellets and are dispensed with a medication guide. The usual dosage should be followed and patients should not accept the bottle if the seal is broken or missing. It is manufactured for Quallent Pharmaceuticals Health LLC and the manufacturing license is 22/RR/AP/2001/FIR. The information on usage and storage can be found on the package insert. There is also a small section mentioning the manufacturer, Hetero Labs Limited in Hyderabad, India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.